Prognostic factors of efficacy of eradication therapy in patients with duodenal ulcer
Kozlova, I.V.; Eliseev, I.I.; Pakhomova, A.L.; Khan, S.A.
Klinicheskaia Meditsina 83(7): 52-55
2005
ISSN/ISBN: 0023-2149 PMID: 16117427 Document Number: 591252
The aim of the study was to determine microorganism-associated predictors of efficacy of eradication therapy in patients with Helicobacter pylori-associated duodenal ulcer. The subjects were 129 such patients. Clinical, endoscopic, microbiological, and immunological examination revealed differences in the initial immune status, the structure of gastroduodenal zone mucosa, and large bowel biocenosis, which predict efficacy of eradication therapy.
Document emailed within 1 workday
Related Documents
Iser, J.H.; Buttigieg, R.J.; Iseli, A. 1994: Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer Medical Journal of Australia 160(4): 192-196Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G. 1993: Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease Medizinische Klinik 88(5): 297-299
Maeyama, S.; Yoshihara, H.; Kamada, T.; Kubota, S.; Kobayashi, I.; Tsuji, S.; Kawano, S. 2005: Effect of maintenance therapy by H2RA on the recurrence of gastric and duodenal ulcer and on the occurrence of reflux esophagitis, gastric erosions, and duodenal erosions after H. pylori eradication Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 11): 512-515
Frotz, H.; Ahrends, H.; Hebbeln, H.; Klass, D.; Miederer, S.E.; Mittelstaedt, A.; Rolfs, H.C.; von Geldern, R. 1995: Ranitidine and clarithromycin for eradication of Helicobacter pylori in patients with duodenal ulcer Arzneimittel-Forschung 45(2): 184-186
Reshetniak, V.I.; Dudik, T.V.; Solov'eva, N.A.; Zhukhovitskiĭ, V.G.; Il'chenko, A.A.; Kaprel'iants, A.S. 2002: Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin Antibiotiki i Khimioterapiia 47(2): 16-19
Calam, J. 1998: The effect of Helicobacter pylori eradication on maximal acid secretion in duodenal ulcer patients; findings and mechanisms Italian Journal of Gastroenterology and Hepatology 30(4): 368-369
Osipenko, M.F.; Pankova, L.I.; Bikbulatova, E.A. 2003: Medico-economic efficacy of eradication schemes in helicobacter infections in patients with duodenal ulcers Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 34-36; 116
Penston, J.; Wormsley, K.G. 1990: Long-term maintenance therapy in duodenal ulcer. Efficacy and safety Fortschritte der Medizin 108(14): 282-286
Chearanai, O.; Kachintorn, U.; Plengvanit, U. 1987: Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer Journal of the Medical Association of Thailand 70(4): 176-180
Hu, F.L.; Jia, B.Q.; Chen, B.W. 1987: Ranitidine and cimetidine in short-term treatment of duodenal ulcer and their acid inhibitory effect in patients with duodenal ulcer Zhonghua Nei Ke Za Zhi 26(8): 468-470; 510
Ben Ammar, A.; Cheikh, I.; Ouerghi, H.; Chaabouni, H.; Kchaou, M.; Ben Mami, N. 2002: Prevalence of Helicobacter pylori infection in duodenal ulcer. Data of a prospective study apropos of 78 NSAID-negative patients with duodenal ulcer La Tunisie Medicale 80(10): 599-604
Kirika, N.V.; Bodrug, N.I.; Butorov, S.I.; Verbitskiĭ, O.N.; Ridlovskiĭ, A.I.; Butorov, I.V.; Lagutkin, D.I.; Martyniuk, L.I. 2003: Clinical efficacy of combined anti-Helicobacter treatment of patients with duodenal ulcer Klinicheskaia Meditsina 81(1): 37-39
Yukselen, V.; Yasa, M.Hadi.; Karaoglu, A.Onder. 2003: In treatment of active duodenal ulcer and Helicobacter pylori eradication Hepato-Gastroenterology 50 Suppl. 2: Cccvi-Cccviii
Kumar, D.; Dhar, A.; Dattagupta, S.; Ahuja, V.; Mathur, M.; Sharma, M.P. 2002: Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 21(1): 7-10
Pohle, T.; Hilker, E.; Domschke, W. 1997: Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication Zeitschrift für Gastroenterologie 35(7): 563-565
Fernández Muñoz, J.; López de Andrés, A.; Zapater Hernández, P.; Abad Santos, F. 1998: Cost-effectiveness analysis of the eradication of Helicobacter pylori as treatment for duodenal ulcer Anales de Medicina Interna 15(10): 515-522
Bondar', Z.A.; Berezina, L.V.; Feklisova, M.E. 1971: Methods of increasing the efficacy of dispensary care of patients with gastrics and duodenal ulcer under medical center conditions Terapevticheskii Arkhiv 43(6): 3-7
Aliev, M.A.; Verbolovich, V.P.; Teplova, L.L.; Kishkin, K.A. 1985: Neuroendocrine factors in determining the indications for vagotomy in patients with duodenal ulcer Klinicheskaia Meditsina 63(7): 109-114
Lim, L.-G.; Yeoh, K.-G.; Wai, C.-T. 2008: Metastatic pancreatic cancer presenting as a bleeding duodenal ulcer 30 months after initial diagnosis of duodenal ulcer. Should duodenal ulcers be biopsied or followed up with repeat endoscopy? Acta Gastro-Enterologica Belgica 71(3): 347-348
Tulassay, Z.; Szathmári, M.; Papp, J. 1988: Combined antisecretory therapy in patients with duodenal ulcer Wiener Medizinische Wochenschrift 138(4): 73-75